FTSE recovery grinds to a halt

Drugs giant GlaxoSmithKline gave investors a headache today as the London market’s recent resurgence ground to a halt.

FTSE recovery grinds to a halt

Drugs giant GlaxoSmithKline gave investors a headache today as the London market’s recent resurgence ground to a halt.

The FTSE 100 Index shed 112 points to end the day hanging on above the 4,000 barrier at 4006.9 as heavyweight stocks slipped back.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited